Utility of Bilirubins and Bile Acids as Endogenous Biomarkers for the Inhibition of Hepatic Transporters

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Drug Metabolism And Disposition

• Publication date

  2015-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/dmd.114.061051PMID 25581390
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vitro OATP1B1 and OATP1B3 inhibition is associated with observations of benign clinical unconjugated hyperbilirubinemia

  2014cited by this paper
• The Roles of MRP2, MRP3, OATP1B1, and OATP1B3 in Conjugated Hyperbilirubinemia

  2014cited by this paper
• Pitavastatin is a more sensitive and selective organic anion-transporting polypeptide 1B clinical probe than rosuvastatin.

  2014cited by this paper
• 6β-Hydroxycortisol Is an Endogenous Probe for Evaluation of Drug–Drug Interactions Involving a Multispecific Renal Organic Anion Transporter, OAT3/SLC22A8, in Healthy Subjects

  2014cited by this paper
• Cyclosporine Inhibition of Hepatic and Intestinal CYP3A4, Uptake and Efflux Transporters: Application of PBPK Modeling in the Assessment of Drug-Drug Interaction Potential

  2013cited by this paper
• Evaluation of Oatp and Mrp2 Activities in Hepatobiliary Excretion Using Newly Developed Positron Emission Tomography Tracer [11C]Dehydropravastatin in Rats

  2013cited by this paper
• Evaluating the in vitro inhibition of UGT1A1, OATP1B1, OATP1B3, MRP2, and BSEP in predicting drug-induced hyperbilirubinemia.

  2013cited by this paper
• Hepatocellular Organic Anion–Transporting Polypeptides (OATPs) and Multidrug Resistance–Associated Protein 2 (MRP2) Are Inhibited by Silibinin

  2013cited by this paper
• Integrated Approach of In Vivo and In Vitro Evaluation of the Involvement of Hepatic Uptake Organic Anion Transporters in the Drug Disposition in Rats Using Rifampicin as an Inhibitor

  2013cited by this paper
• Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver.

  2012influential reference
• Long-lasting inhibitory effects of cyclosporin A, but not tacrolimus, on OATP1B1- and OATP1B3-mediated uptake.

  2012cited by this paper
• A high throughput in vitro mrp2 assay to predict in vivo biliary excretion

  2012cited by this paper
• Transporter‐Mediated Drug–Drug Interactions Involving OATP Substrates: Predictions Based on In Vitro Inhibition Studies

  2012cited by this paper
• N‐Methylnicotinamide Is an Endogenous Probe for Evaluation of Drug–Drug Interactions Involving Multidrug and Toxin Extrusions (MATE1 and MATE2‐K)

  2012cited by this paper
• Identification of the Rate‐Determining Process in the Hepatic Clearance of Atorvastatin in a Clinical Cassette Microdosing Study

  2011cited by this paper
• Prediction of Fluoroquinolone‐Induced Elevation in Serum Creatinine Levels: A Case of Drug–Endogenous Substance Interaction Involving the Inhibition of Renal Secretion

  2011cited by this paper
• The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.

  2011influential reference
• Estimation of Transporters Involved in the Hepatobiliary Transport of TA-0201CA Using Sandwich-Cultured Rat Hepatocytes from Normal and Multidrug Resistance-Associated Protein 2-Deficient Rats

  2010cited by this paper
• Long-Lasting Inhibition of the Transporter-Mediated Hepatic Uptake of Sulfobromophthalein by Cyclosporin A in Rats

  2009cited by this paper
• Prediction of the Hepatic and Renal Clearance of Transporter Substrates in Rats Using in Vitro Uptake Experiments

  2009cited by this paper
• SLCO1B1 variants and statin-induced myopathy--a genomewide study.

  2008cited by this paper
• Involvement of Multiple Transporters in the Hepatobiliary Transport of Rosuvastatin

  2008cited by this paper
• 4‐phenylbutyrate enhances the cell surface expression and the transport capacity of wild‐type and mutated bile salt export pumps

  2007cited by this paper
• Effect of OATP1B Transporter Inhibition on the Pharmacokinetics of Atorvastatin in Healthy Volunteers

  2007cited by this paper
• Multiple Transporters Affect the Disposition of Atorvastatin and Its Two Active Hydroxy Metabolites: Application of in Vitro and ex Situ Systems

  2006cited by this paper
• INVOLVEMENT OF TRANSPORTERS IN THE HEPATIC UPTAKE AND BILIARY EXCRETION OF VALSARTAN, A SELECTIVE ANTAGONIST OF THE ANGIOTENSIN II AT1-RECEPTOR, IN HUMANS

  2006cited by this paper
• GLUCURONIDATION CONVERTS GEMFIBROZIL TO A POTENT, METABOLISM-DEPENDENT INHIBITOR OF CYP2C8: IMPLICATIONS FOR DRUG-DRUG INTERACTIONS

  2006cited by this paper
• OATP 1 B 1 , OATP 1 B 3 , AND MRP 2 ARE INVOLVED IN HEPATOBILIARY TRANSPORT OF OLMESARTAN , A NOVEL ANGIOTENSIN II BLOCKER

  2006cited by this paper
• OATP1B1, OATP1B3, AND MRP2 ARE INVOLVED IN HEPATOBILIARY TRANSPORT OF OLMESARTAN, A NOVEL ANGIOTENSIN II BLOCKER

  2006cited by this paper
• Cyclosporine markedly raises the plasma concentrations of repaglinide

  2005cited by this paper
• RELATIONSHIP BETWEEN EXPOSURE AND NONSPECIFIC BINDING OF THIRTY-THREE CENTRAL NERVOUS SYSTEM DRUGS IN MICE

  2005influential reference
• Validated assays for human cytochrome P450 activities.

  2004cited by this paper
• Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the Hepatic Uptake of Pitavastatin in Humans

  2004cited by this paper
• Inhibition of human organic anion transporting polypeptide OATP 1B1 as a mechanism of drug-induced hyperbilirubinemia.

  2004cited by this paper
• Role of organic anion-transporting polypeptides, OATP-A, OATP-C and OATP-8, in the human placenta-maternal liver tandem excretory pathway for foetal bilirubin.

  2003cited by this paper
• Substrate specificities of rat oatp1 and ntcp: implications for hepatic organic anion uptake.

  2003cited by this paper
• Bile acid regulation of hepatic physiology: I. Hepatocyte transport of bile acids.

  2003cited by this paper
• Functional expression of the canalicular bile salt export pump of human liver.

  2002influential reference
• Mechanism of indinavir-induced hyperbilirubinemia.

  2001cited by this paper
• Hepatic Uptake of Bilirubin and Its Conjugates by the Human Organic Anion Transporter SLC21A6*

  2001influential reference
• Localization of organic anion transporting polypeptide 4 (Oatp4) in rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3

  2001cited by this paper
• Rifamycin SV and rifampicin exhibit differential inhibition of the hepatic rat organic anion transporting polypeptides, Oatp1 and Oatp2

  2000cited by this paper
• In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin.

  2000cited by this paper
• Differential effects of jaundice and cirrhosis on beta-adrenoceptor signaling in three rat models of cirrhotic cardiomyopathy.

  1999cited by this paper
• Transport of monoglucuronosyl and bisglucuronosyl bilirubin by recombinant human and rat multidrug resistance protein 2

  1999cited by this paper
• Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.

  1999cited by this paper
• The Sister of P-glycoprotein Represents the Canalicular Bile Salt Export Pump of Mammalian Liver*

  1998cited by this paper
• A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis

  1998cited by this paper
• Jaundice and disorders of bilirubin metabolism

  1998cited by this paper
• [Establishment of hyperbilirubinuria rat mutant--a new animal model for jaundice].

  1994cited by this paper
• Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter.

  1994influential reference
• Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia.

  1993cited by this paper
• Equilibrium dialysis, ultrafiltration, and ultracentrifugation compared for determining the plasma-protein-binding characteristics of valproic acid.

  1985cited by this paper
• The effect of an intravenous infusion of rifamycin SV on the excretion of bilirubin, bromsulphalein, and indocyanine green in man.

  1965cited by this paper

• Role of solute carrier transporters in the biodistribution and toxicity of chemotherapeutic drugs.

  2026cites this paper
• Recent advances in mass spectrometry-based bioanalytical methods for endogenous biomarkers analysis in transporter-mediated drug-drug interactions

  2025cites this paper
• Albumin-bound kynurenic acid is an appropriate endogenous biomarker for assessment of the renal tubular OATs-MRP4 channel

  2023cites this paper
• Characterization of Bile Acid Sulfate Conjugates as Substrates of Human Organic Anion Transporting Polypeptides.

  2023cites this paper
• Cyanidin 3-glucoside targets a hepatic bilirubin transporter in rats.

  2022cites this paper
• Special Section on Bile Acids, Drug Metabolism, and Toxicity — Minireview Environmental Chemical Contribution to the Modulation of Bile Acid Homeostasis and Farnesoid X Receptor Signaling

  2022influential citation
• Endogenous Biomarkers for SLC Transporter-Mediated Drug-Drug Interaction Evaluation

  2021cites this paper
• Cyanidin 3-glucoside Is a Selective Inhibitor of Hepatic Bilirubin Uptake

  2021cites this paper
• Environmental Chemical Contribution to the Modulation of Bile Acid Homeostasis and Farnesoid X Receptor Signaling

  2021influential citation
• Anticholestatic Effect of Bardoxolone Methyl on Hepatic Ischemia-reperfusion Injury in Rats

  2020cites this paper
• Use of imaging to assess the activity of hepatic transporters

  2020cites this paper
• Organic Anion Transporter Polypeptide 1B1 Polymorphism Modulates the Extent of Drug–Drug Interaction and Associated Biomarker Levels in Healthy Volunteers

  2019cites this paper
• Effects of Hepatic Ischemia-Reperfusion Injuries and NRF2 on Transcriptional Activities of Bile Transporters in Rats.

  2019cites this paper
• Synthesis of functionalized dihydro-2-oxopyrroles using graphene oxide as heterogeneous catalyst

  2018cites this paper
• A multi-center preclinical study of gadoxetate DCE-MRI in rats as a biomarker of drug induced inhibition of liver transporter function

  2018cites this paper
• Biomarkers for In Vivo Assessment of Transporter Function

  2018influential citation
• Endogenous Biomarkers to Assess Drug-Drug Interactions by Drug Transporters and Enzymes.

  2017cites this paper
• Membrane Transporters for Bilirubin and Its Conjugates: A Systematic Review

  2017influential citation
• Evaluation of transporters in drug development: Current status and contemporary issues☆

  2017cites this paper
• Antibiotic‐Induced Elevations of Plasma Bile Acids in Rats Independent of Bsep Inhibition

  2017cites this paper
• Beyond drug-drug interactions: effects of transporter inhibition on endobiotics, nutrients and toxins

  2017cites this paper
• Comparative Evaluation of Dehydroepiandrosterone Sulfate Potential to Predict Hepatic Organic Anion Transporting Polypeptide Transporter-Based Drug-Drug Interactions

  2017cites this paper
• Identification of Endogenous Biomarkers to Predict the Propensity of Drug Candidates to Cause Hepatic or Renal Transporter-Mediated Drug-Drug Interactions.

  2017cites this paper
• Assessing the Risk of Drug-Induced Cholestasis Using Unbound Intrahepatic Concentrations

  2017cites this paper
• Coproporphyrins I and III as Functional Markers of OATP1B Activity: In Vitro and In Vivo Evaluation in Preclinical Species

  2016cites this paper
• Bile acids in drug induced liver injury: Key players and surrogate markers.

  2016cites this paper
• Recommendation to Exclude Bile-Duct-Cannulated Rats with Hyperbilirubinemia for Proper Conduct of Biliary Drug Excretion Studies

  2016cites this paper
• Metabolomic and Genome‐wide Association Studies Reveal Potential Endogenous Biomarkers for OATP1B1

  2016cites this paper
• Inhibition of hepatic cytochrome P450 enzymes and sodium/bile acid cotransporter exacerbates leflunomide-induced hepatotoxicity

  2016cites this paper
• The Promise of New Technologies to Reduce, Refine, or Replace Animal Use while Reducing Risks of Drug Induced Liver Injury in Pharmaceutical Development.

  2016cites this paper
• Coproporphyrins in Plasma and Urine Can Be Appropriate Clinical Biomarkers to Recapitulate Drug-Drug Interactions Mediated by Organic Anion Transporting Polypeptide Inhibition

  2016cites this paper
• Insights into solute carriers: physiological functions and implications in disease and pharmacokinetics

  2016cites this paper
• Comparative evaluation of dehydroepiandrosterone sulfate (DHEAS) potential to predict hepatic OATP transporter-based drug-drug interactions

  2016cites this paper
• Development of analytical method for simultaneous determination of five rodent unique bile acids in rat plasma using ultra-performance liquid chromatography coupled with time-of-flight mass spectrometry.

  2015cites this paper
• Minimizing DILI risk in drug discovery - A screening tool for drug candidates.

  2015cites this paper